Byron J. Gajewski, Ph.D. - Publications

Affiliations: 
2000 Texas A & M University, College Station, TX, United States 
Area:
Statistics

84 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Shi X, Mudaranthakam DP, Wick JA, Streeter D, Thompson JA, Streeter NR, Lin TL, Hines J, Mayo MS, Gajewski BJ. Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer center. Contemporary Clinical Trials Communications. 38: 101281. PMID 38419809 DOI: 10.1016/j.conctc.2024.101281  0.634
2023 Gao G, Wick JA, Brown AR, Barohn RJ, Gajewski BJ. Using a Bayesian model of the joint distribution of pain and time on medication to decide on pain medication for neuropathy. Communications in Statistics. Case Studies, Data Analysis and Applications. 9: 252-269. PMID 37692073 DOI: 10.1080/23737484.2023.2212262  0.606
2023 Christifano DN, Chollet-Hinton L, Mathis NB, Gajewski BJ, Carlson SE, Colombo J, Gustafson KM. DHA Supplementation During Pregnancy Enhances Maternal Vagally Mediated Cardiac Autonomic Control in Humans. The Journal of Nutrition. 152: 2708-2715. PMID 37230667 DOI: 10.1093/jn/nxac178  0.361
2023 Duan J, Gajewski BJ, Sen P, Wick JA. Assessing the incidence and severity of drug adverse events: a Bayesian hierarchical cumulative logit model. Journal of Biopharmaceutical Statistics. 1-20. PMID 37016726 DOI: 10.1080/10543406.2023.2194385  0.634
2022 Gao G, Gajewski BJ, Wick J, Beall J, Saver JL, Meinzer C. Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients. Trials. 23: 754. PMID 36068547 DOI: 10.1186/s13063-022-06664-4  0.626
2022 Christifano DN, Gustafson KM, Carlson SE, Sultanna N, Brown A, Sands SA, Colombo J, Gajewski BJ. Maternal Docosahexaenoic Acid Exposure Needed to Achieve Maternal-Newborn EQ. Nutrients. 14. PMID 36014806 DOI: 10.3390/nu14163300  0.42
2022 Christifano DN, Chollet-Hinton L, Mathis NB, Gajewski BJ, Carlson SE, Colombo J, Gustafson KM. DHA Supplementation during Pregnancy Enhances Maternal Vagally-Mediated Cardiac Autonomic Control in Humans. The Journal of Nutrition. PMID 35953431 DOI: 10.1093/jn/nxac178  0.36
2022 Tang F, Befort CA, Wick J, Gajewski BJ. Unifying the analysis of continuous and categorical measures of weight loss and incorporating group effect: a secondary re-analysis of a large cluster randomized clinical trial using Bayesian approach. Bmc Medical Research Methodology. 22: 28. PMID 35081912 DOI: 10.1186/s12874-021-01499-0  0.643
2021 Tang F, Carlson S, Wick J, Gajewski BJ. Bayesian EMAX model with a mixture of normal distributions for dose-response in clinical trials. Contemporary Clinical Trials. 110: 106571. PMID 34555517 DOI: 10.1016/j.cct.2021.106571  0.615
2021 Gustafson KM, Christifano DN, Hoyer D, Schmidt A, Carlson SE, Colombo J, Mathis NB, Sands SA, Chollet-Hinton L, Brown AR, Mudaranthakam DP, Gajewski BJ. Prenatal docosahexaenoic acid effect on maternal-infant DHA-equilibrium and fetal neurodevelopment: a randomized clinical trial. Pediatric Research. PMID 34552200 DOI: 10.1038/s41390-021-01742-w  0.393
2021 Pal Mudaranthakam D, Park M, Thompson J, Alsup AM, Krebill R, Chollet Hinton L, Hu J, Gajewski B, Godwin A, Mayo MS, Wick J, Harlan-Williams L, He J, Gurley-Calvez T. A framework for personalized mammogram screening. Preventive Medicine Reports. 23: 101446. PMID 34168953 DOI: 10.1016/j.pmedr.2021.101446  0.666
2021 Cernik C, Shergina E, Thompson J, Blackwell K, Stephens K, Kimminau KS, Wick J, Mayo MS, Gajewski B, He J, Mudaranthakam DP. Non-cancer clinical trials start-up metrics at an academic medical center: Implications for advancing research. Contemporary Clinical Trials Communications. 22: 100774. PMID 34027224 DOI: 10.1016/j.conctc.2021.100774  0.71
2021 Milling TJ, Warach S, Johnston SC, Gajewski BJ, Costantini T, Price M, Wick J, Roward S, Mudaranthakam D, Dula AN, King B, Muddiman A, Lip G. Restart TICrH Trial Design: an adaptive randomized trial of time intervals to restart direct oral anticoagulants after traumatic intracranial hemorrhage. Journal of Neurotrauma. PMID 33470152 DOI: 10.1089/neu.2020.7535  0.61
2021 Zhang C, Mayo MS, Wick JA, Gajewski BJ. Designing and analyzing clinical trials for personalized medicine via Bayesian models. Pharmaceutical Statistics. PMID 33463906 DOI: 10.1002/pst.2095  0.646
2020 Mudaranthakam DP, Cernik C, Curtis L, Griffith B, Hu J, Wick J, Thompson J, Gajewski B, Koestler D, Jensen RA, Mayo MS. Utilization of Technology to Improve Efficiency in Investigational Drug Management Processes. The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians. 36: 84-90. PMID 34752537 DOI: 10.1177/8755122519900049  0.599
2020 King B, Milling T, Gajewski B, Costantini TW, Wick J, Price MA, Mudaranthakam D, Stein DM, Connolly S, Valadka A, Warach S. Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials. Trauma Surgery & Acute Care Open. 5: e000605. PMID 33313417 DOI: 10.1136/tsaco-2020-000605  0.626
2020 Liu J, Wick J, Martin RH, Meinzer C, Roy D, Gajewski B. Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials. Bmc Medical Research Methodology. 20: 227. PMID 32912172 DOI: 10.1186/S12874-020-01114-8  0.664
2020 Kasenda B, Liu J, Jiang Y, Gajewski B, Wu C, von Elm E, Schandelmaier S, Moffa G, Trelle S, Schmitt AM, Herbrand AK, Gloy V, Speich B, Hopewell S, Hemkens LG, et al. Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study. Trials. 21: 731. PMID 32825846 DOI: 10.1186/S13063-020-04666-8  0.483
2020 Liu J, Wick J, Martin RH, Meinzer C, Roy D, Gajewski B. Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials. Bmc Medical Research Methodology. 20: 211. PMID 32807102 DOI: 10.1186/S12874-020-01097-6  0.648
2020 Huang X, Gajewski BJ. Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials. Bmc Medical Research Methodology. 20: 194. PMID 32690004 DOI: 10.1186/S12874-020-01071-2  0.305
2020 Yeatts SD, Martin RH, Meurer W, Silbergleit R, Rockswold G, Barsan WG, Korley FK, Wright D, Gajewski BJ. Sliding Scoring of the Glasgow Outcome Scale - Extended (GOS-E) as Primary Outcome in Traumatic Brain Injury Trials. Journal of Neurotrauma. PMID 32664792 DOI: 10.1089/Neu.2019.6969  0.307
2020 Mudaranthakam DP, Phadnis MA, Krebill R, Clark L, Wick JA, Thompson J, Keighley J, Gajewski BJ, Koestler DC, Mayo MS. Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials. Contemporary Clinical Trials Communications. 18: 100579. PMID 32510004 DOI: 10.1016/J.Conctc.2020.100579  0.679
2020 Liu J, Wick J, Jiang Y, Mayo M, Gajewski B. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times. Pharmaceutical Statistics. PMID 32319194 DOI: 10.1002/Pst.2025  0.698
2019 Karanevich A, Meier R, Graw S, McGlothlin A, Gajewski B. Optimizing Sample Size Allocation and Power in a Bayesian Two-Stage Drop-the-Losers Design The American Statistician. 1-10. PMID 32981939 DOI: 10.1080/00031305.2019.1610065  0.312
2019 Gajewski BJ, Statland J, Barohn R. Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness Trials. Statistics in Biopharmaceutical Research. 11: 375-386. PMID 31839873 DOI: 10.1080/19466315.2019.1610044  0.35
2019 Mudaranthakam DP, Shergina E, Park M, Thompson J, Streeter D, Hu J, Wick J, Gajewski B, Koestler DC, Godwin AK, Jensen RA, Mayo MS. Optimizing Retrieval of Biospecimens Using the Curated Cancer Clinical Outcomes Database (C3OD). Cancer Informatics. 18: 1176935119886831. PMID 31798300 DOI: 10.1177/1176935119886831  0.653
2019 Liu J, Wick JA, Mudaranthakam DP, Jiang Y, Mayo MS, Gajewski BJ. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies. Clinical Trials (London, England). 1740774519871474. PMID 31451012 DOI: 10.1177/1740774519871474  0.695
2019 Gajewski BJ, Meinzer C, Berry SM, Rockswold GL, Barsan WG, Korley FK, Martin RH. Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials. Statistics in Medicine. PMID 31070807 DOI: 10.1002/Sim.8167  0.338
2019 Colombo J, Shaddy DJ, Gustafson K, Gajewski BJ, Thodosoff JM, Kerling E, Carlson SE. The Kansas University DHA Outcomes Study (KUDOS) clinical trial: long-term behavioral follow-up of the effects of prenatal DHA supplementation. The American Journal of Clinical Nutrition. PMID 31004139 DOI: 10.1093/Ajcn/Nqz018  0.481
2018 Karanevich A, He J, Gajewski BJ. Using an Anchor to Improve Linear Predictions with Application to Predicting Disease Progression. Revista Colombiana De Estadistica. 41: 137-155. PMID 30686847 DOI: 10.15446/Rce.V41N2.68535  0.522
2018 Karanevich AG, Weisbrod LJ, Jawdat O, Barohn RJ, Gajewski BJ, He J, Statland JM. Using automated electronic medical record data extraction to model ALS survival and progression. Bmc Neurology. 18: 205. PMID 30547800 DOI: 10.1186/S12883-018-1208-Z  0.497
2018 Carlson SE, Gajewski BJ, Alhayek S, Colombo J, Kerling EH, Gustafson KM. Dose-response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 138: 1-5. PMID 30392575 DOI: 10.1016/J.Plefa.2018.09.002  0.513
2018 Zhang C, Mayo MS, Gajewski BJ. Comments on "Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials". Statistics in Medicine. 37: 2900-2901. PMID 30294062 DOI: 10.1002/Sim.7678  0.341
2018 Karanevich AG, Statland JM, Gajewski BJ, He J. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. Bmc Medical Research Methodology. 18: 19. PMID 29409450 DOI: 10.1186/S12874-018-0479-9  0.485
2017 Lei Y, Carlson S, Yelland LN, Makrides M, Gibson R, Gajewski BJ. Comparison of Dichotomized and Distributional Approaches in Rare Event Clinical Trial Design: a Fixed Bayesian Design. Journal of Applied Statistics. 44: 1466-1478. PMID 28503016 DOI: 10.1080/02664763.2016.1214244  0.369
2017 Lei Y, Mayo MS, Carlson SE, Gajewski BJ. Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial. Contemporary Clinical Trials Communications. 5: 116-122. PMID 28217765 DOI: 10.1016/J.Conctc.2017.01.002  0.345
2017 Carlson SE, Gajewski BJ, Valentine CJ, Rogers LK, Weiner CP, DeFranco EA, Buhimschi CS. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol. Bmc Pregnancy and Childbirth. 17: 62. PMID 28193189 DOI: 10.1186/S12884-017-1244-5  0.315
2017 Zhang C, Garrard L, Keighley J, Carlson S, Gajewski B. Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design. Bmc Pregnancy and Childbirth. 17: 18. PMID 28068927 DOI: 10.1186/S12884-016-1189-0  0.304
2016 Bott M, Karanevich AG, Garrard L, Price LR, Mudaranthakam DP, Gajewski B. Confirmatory Factor Analysis Alternative: Free, Accessible CBID Software. Western Journal of Nursing Research. PMID 27920348 DOI: 10.1177/0193945916681564  0.303
2016 Richter KP, Hunt JJ, Cupertino AP, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD. Commitment and Capacity for Providing Evidence-Based Tobacco Treatment in U.S. Drug Treatment Facilities. Substance Abuse. 0. PMID 27897468 DOI: 10.1080/08897077.2016.1265039  0.354
2016 Garrard L, Price LR, Bott MJ, Gajewski BJ. A novel method for expediting the development of patient-reported outcome measures and an evaluation across several populations. Applied Psychological Measurement. 40: 455-468. PMID 27667878 DOI: 10.1177/0146621616652634  0.334
2016 Yelland LN, Gajewski BJ, Colombo J, Gibson RA, Makrides M, Carlson SE. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 112: 44-9. PMID 27637340 DOI: 10.1016/J.Plefa.2016.08.007  0.532
2016 Brown AR, Gajewski BJ, Aaronson LS, Mudaranthakam DP, Hunt SL, Berry SM, Quintana M, Pasnoor M, Dimachkie MM, Jawdat O, Herbelin L, Barohn RJ. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization. Trials. 17: 428. PMID 27577191 DOI: 10.1186/S13063-016-1544-5  0.37
2016 Shireman TI, Kerling EH, Gajewski BJ, Colombo J, Carlson SE. Docosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 111: 8-10. PMID 27499448 DOI: 10.1016/J.Plefa.2016.05.008  0.46
2016 Jiang Y, Guarino P, Ma S, Simon S, Mayo MS, Raghavan R, Gajewski BJ. Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application. Trials. 17: 336. PMID 27449769 DOI: 10.1186/S13063-016-1457-3  0.445
2016 Colombo J, Gustafson KM, Gajewski BJ, Shaddy DJ, Kerling EH, Thodosoff JM, Doty T, Brez CC, Carlson SE. Prenatal DHA Supplementation and Infant Attention. Pediatric Research. PMID 27362506 DOI: 10.1038/Pr.2016.134  0.474
2016 Gajewski BJ, Reese CS, Colombo J, Carlson SE. Commensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials. Statistics in Biopharmaceutical Research. 8: 151-160. PMID 27347357 DOI: 10.1080/19466315.2015.1133453  0.53
2016 Gajewski BJ, Berry SM, Barsan WG, Silbergleit R, Meurer WJ, Martin R, Rockswold GL. Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling. Pharmaceutical Statistics. PMID 27306921 DOI: 10.1002/Pst.1755  0.356
2016 Wick J, Berry SM, Yeh HW, Choi W, Pacheco CM, Daley C, Gajewski BJ. A Novel Evaluation of Optimality for Randomized Controlled Trials. Journal of Biopharmaceutical Statistics. PMID 27295566 DOI: 10.1080/10543406.2016.1198367  0.632
2016 Karanevich A, Statland J, Gajewski B, Barohn R, Koestler D, He J. Using onset-time to improve ALS disease progression predictions: A Bayesian hierarchical approach F1000research. 5. DOI: 10.7490/F1000Research.1113540.1  0.482
2016 Jiang W, Mayo MS, Gajewski BJ. Dichotomizing Continuous Data Which Retains Statistical Precision Using a Bayesian Distributional Approach That Reflects the True Uncertainty Statistics in Biopharmaceutical Research. 8: 77-87. DOI: 10.1080/19466315.2015.1117016  0.319
2016 Shireman TI, Kerling EH, Gajewski BJ, Colombo J, Carlson SE. Docosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes Prostaglandins Leukotrienes and Essential Fatty Acids. 111: 8-10. DOI: 10.1016/j.plefa.2016.05.008  0.391
2015 Staggs VS, Gajewski BJ. Bayesian and frequentist approaches to assessing reliability and precision of health-care provider quality measures. Statistical Methods in Medical Research. PMID 25788482 DOI: 10.1177/0962280215577410  0.311
2015 Gajewski BJ, Berry SM, Quintana M, Pasnoor M, Dimachkie M, Herbelin L, Barohn R. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot. Statistics in Medicine. 34: 1134-49. PMID 25640114 DOI: 10.1002/Sim.6403  0.361
2015 Jiang Y, Simon S, Mayo MS, Gajewski BJ. Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors. Statistics in Medicine. 34: 613-29. PMID 25376910 DOI: 10.1002/Sim.6359  0.467
2014 Jiang Y, Boyle DK, Bott MJ, Wick JA, Yu Q, Gajewski BJ. Expediting Clinical and Translational Research via Bayesian Instrument Development. Applied Psychological Measurement. 38: 296-310. PMID 24882893 DOI: 10.1177/0146621613517165  0.684
2014 Hunt JJ, Cupertino AP, Gajewski BJ, Jiang Y, Ronzani TM, Richter KP. Staff commitment to providing tobacco dependence in drug treatment: Reliability, validity, and results of a national survey. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 28: 389-95. PMID 24128292 DOI: 10.1037/A0034389  0.382
2013 Yeh HW, Jiang Y, Garrard L, Lei Y, Gajewski B. A Bayesian model for censored positive count data in evaluating breast cancer progression. Model Assisted Statistics and Applications : An International Journal. 8: 143-150. PMID 23997758 DOI: 10.3233/Mas-130263  0.402
2013 Hunt JJ, Gajewski BJ, Jiang Y, Cupertino AP, Richter KP. Capacity of US drug treatment facilities to provide evidence-based tobacco treatment. American Journal of Public Health. 103: 1799-801. PMID 23948006 DOI: 10.2105/Ajph.2013.301427  0.363
2013 Cupertino AP, Hunt JJ, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD, Engelman KK, Richter KP. The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Substance Abuse Treatment, Prevention, and Policy. 8: 13. PMID 23497366 DOI: 10.1186/1747-597X-8-13  0.379
2013 Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. DHA supplementation and pregnancy outcomes. The American Journal of Clinical Nutrition. 97: 808-15. PMID 23426033 DOI: 10.3945/Ajcn.112.050021  0.484
2013 Gajewski BJ, Dunton N. Identifying individual changes in performance with composite quality indicators while accounting for regression to the mean. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 396-406. PMID 23035127 DOI: 10.1177/0272989X12461855  0.305
2013 Gajewski BJ, Price LR, Coffland V, Boyle DK, Bott MJ. Integrated analysis of content and construct validity of psychometric instruments Quality and Quantity. 47: 57-78. DOI: 10.1007/S11135-011-9503-4  0.33
2012 Gajewski BJ, Simon SD, Carlson SE. On the Existence of Constant Accrual Rates in Clinical Trials and Direction for Future Research. International Journal of Statistics and Probability. 1: p43. PMID 23869201 DOI: 10.5539/Ijsp.V1N2P43  0.363
2012 Gajewski BJ, Lee R, Dunton N. Data Envelopment Analysis in the Presence of Measurement Error: Case Study from the National Database of Nursing Quality Indicators® (NDNQI®). Journal of Applied Statistics. 39: 2639-2653. PMID 23328796 DOI: 10.1080/02664763.2012.724664  0.321
2012 Yeh HW, Gajewski B, Mukhopadhyay P, Behbod F. The Zero-truncated Poisson with Right Censoring: an Application to Translational Breast Cancer Research. Statistics in Biopharmaceutical Research. 4: 252-263. PMID 23130093 DOI: 10.1080/19466315.2011.636279  0.32
2012 Hou Q, Crosser B, Mahnken JD, Gajewski BJ, Dunton N. Input data quality control for NDNQI national comparative statistics and quarterly reports: a contrast of three robust scale estimators for multiple outlier detection. Bmc Research Notes. 5: 456. PMID 22920157 DOI: 10.1186/1756-0500-5-456  0.325
2012 Pawlowicz FE, Gajewski BJ, Coffland V, Boyle DK, Bott MJ, Dunton N. Application of bayesian methodology to measure equivalence between two rating scales. Nursing Research. 61: 181-7. PMID 22551992 DOI: 10.1097/Nnr.0B013E318253341B  0.304
2012 Gajewski BJ, Coffland V, Boyle DK, Bott M, Price LR, Leopold J, Dunton N. Assessing content validity through correlation and relevance tools a Bayesian randomized equivalence experiment Methodology. 8: 81-96. DOI: 10.1027/1614-2241/A000040  0.315
2011 Hou Q, Mahnken JD, Gajewski BJ, Dunton N. The Box-Cox power transformation on nursing sensitive indicators: does it matter if structural effects are omitted during the estimation of the transformation parameter? Bmc Medical Research Methodology. 11: 118. PMID 21854614 DOI: 10.1186/1471-2288-11-118  0.3
2010 Gajewski BJ, Boyle DK, Miller PA, Oberhelman F, Dunton N. A multilevel confirmatory factor analysis of the Practice Environment Scale: a case study. Nursing Research. 59: 147-53. PMID 20216017 DOI: 10.1097/Nnr.0B013E3181D1A71E  0.306
2010 Mahnken JD, Wick JA, Gajewski BJ, Mayo MS. A study design with conditional, serially assessed co-primary endpoints: An application to a single-arm, pilot non-Hodgkin's lymphoma trial Drug Development Research. 71: 395-403. DOI: 10.1002/Ddr.20387  0.352
2009 Gajewski BJ, Nicholson N, Widen JE. Predicting Hearing Threshold in Nonresponsive Subjects Using a Log-Normal Bayesian Linear Model in the Presence of Left-Censored Covariates Statistics in Biopharmaceutical Research. 1: 137-148. DOI: 10.1198/Sbr.2009.0015  0.366
2009 Gajewski BJ, Lee R, Bott M, Piamjariyakul U, Taunton RL. On estimating the distribution of data envelopment analysis efficiency scores: An application to nursing homes' care planning process Journal of Applied Statistics. 36: 933-944. DOI: 10.1080/02664760802552986  0.745
2009 Park D, Rilett LR, Gajewski BJ, Spiegelman CH, Choi C. Identifying optimal data aggregation interval sizes for link and corridor travel time estimation and forecasting Transportation. 36: 77-95. DOI: 10.1007/S11116-008-9180-X  0.586
2008 Taunton RL, Piamjariyakul U, Gajewski B, Lee RH, Bott MJ. Care planning integrity in nursing facilities. Nursing Research. 57: 271-82. PMID 18641496 DOI: 10.1097/01.Nnr.0000313493.79659.8F  0.324
2008 Carpenter J, Gajewski B, Teel C, Aaronson LS. Bayesian data analysis: estimating the efficacy of T'ai Chi as a case study. Nursing Research. 57: 214-9. PMID 18496107 DOI: 10.1097/01.Nnr.0000319495.59746.B8  0.335
2008 Gajewski BJ, Simon SD, Carlson SE. Predicting accrual in clinical trials with Bayesian posterior predictive distributions. Statistics in Medicine. 27: 2328-40. PMID 17979152 DOI: 10.1002/Sim.3128  0.377
2007 Gajewski BJ, Hart S, Bergquist-Beringer S, Dunton N. Inter-rater reliability of pressure ulcer staging: ordinal probit Bayesian hierarchical model that allows for uncertain rater response. Statistics in Medicine. 26: 4602-18. PMID 17393413 DOI: 10.1002/Sim.2877  0.336
2006 Gajewski BJ, Lee R, Thompson S, Dunton N, Becker A, Wells V. Non-normal path analysis in the presence of measurement error and missing data: a Bayesian analysis of nursing homes' structure and outcomes. Statistics in Medicine. 25: 3632-47. PMID 16374902 DOI: 10.1002/Sim.2478  0.314
2006 Gajewski BJ, Mayo MS. Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors. Statistics in Medicine. 25: 2554-66. PMID 16345057 DOI: 10.1002/Sim.2450  0.305
2006 Gajewski BJ, Thompson S, Dunton N, Becker A, Wrona M. Inter-rater reliability of nursing home surveys: a Bayesian latent class approach. Statistics in Medicine. 25: 325-44. PMID 15977287 DOI: 10.1002/Sim.2224  0.316
2004 Gajewski BJ, Spiegelman CH. Correspondence estimation of the source profiles in receptor modeling Environmetrics. 15: 613-634. DOI: 10.1002/Env.654  0.581
2000 Gajewski BJ, Turner SM, Eisele WL, Spiegelman CH. Intelligent transportation system data archiving: Statistical techniques for determining optimal aggregation widths for inductive loop detector speed data Transportation Research Record. 85-93. DOI: 10.3141/1719-11  0.536
Show low-probability matches.